Updated HPV Vaccine Recommendations Follow Big HPV Infection Drops Shown In New Study
Substantial declines in HPV-related infections and genital warts have led to an expansion in recommendations for the vaccine.
Despite the availability of different therapeutic modalities, treatment of recalcitrant common warts is still challenging. Cervarix, a recombinant bivalent human papillomavirus (HPV) vaccine, has shown promising efficacy in the treatment of warts.
ConclusionsWe found significant disparities in HPV vaccine series completion rates among male patients based on race and insurance, unchanged based on era of initiation or visit frequency.
An analysis covering 66 million young people has found plummeting rates of precancerous lesions and genital warts after vaccination against the human papillomavirus.
By Jacqueline Howard, CNN (CNN) — The US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, known as ACIP, voted unanimously on Wednesday to recommend HPV vaccines for both boys and girls and men and women through age 26. Previously the CDC recommended that teen girls and young women who had not been adequately vaccinated receive the human papillomavirus vaccine through age 26, but the recommendation for teen boys and young men only went through age 21. The CDC’s recommendation that children start receiving two doses of the HPV vaccine around 11 or 12...
Publication date: Available online 26 June 2019Source: The LancetAuthor(s): Mélanie Drolet, Élodie Bénard, Norma Pérez, Marc Brisson, Hammad Ali, Marie-Claude Boily, Vincenzo Baldo, Paul Brassard, Julia M L Brotherton, Denton Callander, Marta Checchi, Eric P F Chow, Silvia Cocchio, Tina Dalianis, Shelley L Deeks, Christian Dehlendorff, Basil Donovan, Christopher K Fairley, Elaine W Flagg, Julia W GarganoSummaryBackgroundMore than 10 years have elapsed since human papillomavirus (HPV) vaccination was implemented. We did a systematic review and meta-analysis of the population-level impact of vacci...
HPV vaccination programmes around the world have significantly cut rates of virus infection, precancerous lesions and genital warts
Conclusion: The response rates after HPV vaccine injection were 90% (complete and partial). Our results suggested that HPV vaccines could be effective in management of genital warts.
A lot of parents ask me, about the HPV vaccine,“Isn’t that the optional one?” Well, let me walk you through why my answer to that question is a hard“no.” Human papillomavirus (HPV) is a virus that causes warts and several types of cancer. There are over 200 different strains of HPV, some of which […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more.
ConclusionsThere are significant disparities in HPV vaccine series completion rates among males based on race and insurance, unchanged based on era of initiation or visit frequency.
Human papillomavirus (HPV) infections are associated with common dermatological and non-dermatological diseases. While HPV vaccines are well-established as preventive measures for genital warts and cervical neoplasia, their use as therapeutic agents deserves greater attention.